Correspondence
Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real-World Situation Even Worse Than Reported?
Daniel Q. Huang M.D.,
Daniel Q. Huang M.D.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Division of Gastroenterology and Hepatology, National University Health System, Singapore
Search for more papers by this author Yee Hui Yeo M.D., M.S.,
Yee Hui Yeo M.D., M.S.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA
Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
Search for more papers by this author Mindie H. Nguyen M.D., M.A.S., A.G.A.F., F.A.A.S.L.D.,
Mindie H. Nguyen M.D., M.A.S., A.G.A.F., F.A.A.S.L.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA
Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA
Search for more papers by this author
Daniel Q. Huang M.D.,
Daniel Q. Huang M.D.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Division of Gastroenterology and Hepatology, National University Health System, Singapore
Search for more papers by this author Yee Hui Yeo M.D., M.S.,
Yee Hui Yeo M.D., M.S.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA
Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
Search for more papers by this author Mindie H. Nguyen M.D., M.A.S., A.G.A.F., F.A.A.S.L.D.,
Mindie H. Nguyen M.D., M.A.S., A.G.A.F., F.A.A.S.L.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA
Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA
Search for more papers by this author
First published: 22 February 2021
No abstract is available for this article.
References
- 1Wolf E, Rich NE, Marrero JA, Parikh ND, Singal AG. Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis. Hepatology 2021; 73: 713-725.
- 2Simmons OL, Feng Y, Parikh ND, Singal AG. Primary care provider practice patterns and barriers to hepatocellular carcinoma surveillance. Clin Gastroenterol Hepatol 2019; 17: 766-773.
- 3Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011; 154: 85-93.
- 4Nguyen MH, Engel-Nitz NM, Bancroft T, Ozbay AB, Singal AG. Gaps in Surveillance for Hepatocellular Carcinoma Among High-Risk Patients in an insured United States Population. Washington, DC: American Public Health Association; 2020.
- 5Mittal S, Kanwal F, Ying J, Chung R, Sada YH, Temple S, et al. Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: a United States cohort. J Hepatol 2016; 65: 1148-1154.
